These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2945187)

  • 21. In vitro inhibitory activity of spiramycin against Haemophilus influenzae.
    Dabernat H; Delmas C
    Chemioterapia; 1987 Jun; 6(2 Suppl):158-9. PubMed ID: 3509933
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of bromazepam (Lexotan) administration on antipyrine pharmacokinetics in humans.
    Allen JG; Galloway DB; Ehsanullah RS; Ruane RJ; Bird HA
    Xenobiotica; 1984 Apr; 14(4):321-6. PubMed ID: 6147049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic metabolism of antipyrine in patients with acute pancreatitis].
    Lukaszyk A
    Przegl Lek; 1987; 44(2):273-6. PubMed ID: 3615930
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acetyl spiramycin].
    Nakamura T; Matsumoto K; Saito J
    J Antibiot B; 1966 Dec; 19(6):428-31. PubMed ID: 5298388
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemotactic response of human polynuclear neutrophils after in vivo administration of spiramycin].
    Lombard JY; Descotes J; Eyraud A; Evreux JC
    J Pharmacol; 1986; 17(3):328-30. PubMed ID: 3795976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlations of kinetics of antipyrine, indocyanine green and bromosulfophthalein in healthy subjects and in patients with cardiovascular diseases].
    Adamska-Dyniewska H; Kowalczyk L
    Pol Tyg Lek; 1978 Jul; 33(29):1143-5. PubMed ID: 704415
    [No Abstract]   [Full Text] [Related]  

  • 28. [Application of acetyl spiramycin to urinary tract infections].
    Shigematsu S; Okochi T; Noda S
    J Antibiot B; 1966 Aug; 19(4):297-304. PubMed ID: 4961327
    [No Abstract]   [Full Text] [Related]  

  • 29. [Basic and clinical study of acetyl-spiramycin].
    Shimizu K; Jindate T; Shimada K; Okumura A
    J Antibiot B; 1966 Dec; 19(6):423-7. PubMed ID: 5298387
    [No Abstract]   [Full Text] [Related]  

  • 30. Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.
    Kessler M; Netter P; Zerrouki M; Renoult E; Trechot P; Dousset B; Jonon B; Mur JM
    Eur J Clin Pharmacol; 1988; 35(3):331-2. PubMed ID: 3053210
    [No Abstract]   [Full Text] [Related]  

  • 31. [Concentration of antibiotics in various jaw tissues: concentration of spiramycin. IV].
    Pignanelli M; Badile S; Tassarotti B; Cruciani S; Scaglione F; Fraschini F
    Dent Cadmos; 1983 Jun; 51(6):73-7. PubMed ID: 6583097
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of the thromboxane synthetase inhibitor Dazoxiben (UK 37-248) on the metabolism of antipyrine in patients with enhanced platelet aggregation.
    Staiger C; Walter E; Wang NS; Schuhmacher E; de Vries J; Weber E
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):250-3. PubMed ID: 6540249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spiramycin resistance in Staphylococcus aureus. The stoichiometry of spiramycin-binding to ribosomes from spiramycin-sensitive, intermediate- and high-resistant strains.
    Shimizu M; Saito T; Mitsuhashi S
    Jpn J Microbiol; 1970 Mar; 14(2):177-8. PubMed ID: 5309854
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Basic study and clinical application of acetyl-spiramycin in surgical field].
    Shibata K; Kuno K; Imazu I; Ito T; Inugai A
    J Antibiot B; 1966 Jun; 19(3):200-5. PubMed ID: 5298422
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on acetyl-spiramycin in gynecology and obstetrics].
    Cho N; Nohara S; Sunada H; Sugiyama S; Kunii K
    J Antibiot B; 1966 Jun; 19(3):211-6. PubMed ID: 5298424
    [No Abstract]   [Full Text] [Related]  

  • 38. Value of liver volume measurement in the study of antipyrine kinetics in liver disease [proceedings].
    Halliwell M; Homeida M; Roberts CJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):393P-394P. PubMed ID: 901719
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug interaction between midecamycin and cyclosporin.
    Finielz P; Mondon JM; Chuet C; Guiserix J
    Nephron; 1995; 70(1):136. PubMed ID: 7617108
    [No Abstract]   [Full Text] [Related]  

  • 40. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.